North America Preclinical Imaging Market (2024-2029)
The North America Preclinical Imaging Market was valued at $1380.1 Million in 2024 and projected to reach to $1768.1 Million by 2029, representing a compound annual growth rate of 5.1%. North America's preclinical imaging market is poised for sustained expansion through 2029, driven by increasing R&D expenditures from pharmaceutical and biotechnology sectors and growing adoption of multimodal imaging platforms.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Preclinical Imaging Market Trends and Insights
- The region is projected to expand to $1,768.1 million by 2029, driven by robust investment in research infrastructure, advanced pharmaceutical development, and strong adoption of imaging technologies across academic and commercial laboratories.
- North America's leadership is underpinned by the presence of major research institutions, well-established regulatory frameworks, and high R&D spending in the life sciences sector. The preclinical imaging market in North America is experiencing steady growth at a compound annual growth rate (CAGR) of 5.1% over the forecast period.
- North America benefits from early adoption of cutting-edge imaging modalities, including micro-CT, micro-MRI, and optical imaging systems, which are essential for drug discovery and development workflows.
- The region's competitive advantage stems from its concentration of pharmaceutical companies, contract research organizations (CROs), and academic medical centers that drive continuous demand for innovative preclinical imaging solutions..
Key Market Statistics
- CAGR (2024-2029) 5.1% CAGR
- Market Size, 2024 ~USD 1380.1 Million
- Forecast, 2029 ~USD 1768.1 Million
- Geography North America
North America Preclinical Imaging Market Overview
Market Leadership Position :
North America holds a commanding share of the global preclinical imaging market, valued at $1,380.1 million in 2024, reflecting the region's dominance in research and development infrastructure.
Strong Growth Trajectory :
The region is projected to grow at a CAGR of 5.1% through 2029, reaching $1,768.1 million, outpacing the global average of 5% and demonstrating sustained investment momentum.
Research Infrastructure Investment :
Robust funding from NIH, NSF, and private institutions drives continuous adoption of advanced preclinical imaging technologies across North American academic and commercial laboratories.
Pharmaceutical Development Hub :
North America's concentration of major pharmaceutical and biotech companies accelerates demand for cutting-edge preclinical imaging solutions in drug discovery and development pipelines.
North America Preclinical Imaging Market Dynamics
- The region's well-established research infrastructure, coupled with significant government and private funding, creates a favorable environment for technology innovation and market penetration. Key growth drivers include the rising complexity of drug development, regulatory requirements for preclinical validation, and the shift toward personalized medicine approaches.
- Academic institutions and contract research organizations (CROs) across the US and Canada continue to upgrade imaging capabilities, while technological advancements in resolution and speed enhance competitive positioning for market participants..
Market Ecosystem
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- North America's preclinical imaging market is valued at $1,380.1 million in 2024 and will grow to $1,768.1 million by 2029.
- North America maintains a 5.1% CAGR, reflecting steady demand from pharmaceutical and biotech sectors.
- North America leads in technology adoption, with widespread use of micro-CT, micro-MRI, and optical imaging systems.
- North America's market growth is supported by strong R&D investment, academic research institutions, and established CRO networks.
Preclinical Imaging Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | NUCLEAR IMAGING SYSTEMS (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 4 (2024) |
| Revenue Forecast (Billions) | ~USD 5.1 (2029) |
| Segments Covered | Product, Type, Application, End User |
North America Preclinical Imaging Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- Imaging Systems
- Reagents
- Software
By Type
- Barium-Based Contrast Agents
- Bioluminescence Imaging Systems
- Fluorescence Imaging Systems
- Gadolinium-Based Contrast Agents
- Gallium-67-Based Spect Probes
- Gastrografin-Based Contrast Agents
- Gold Nanoparticles
- Iodine-131-Based Spect Probes
- Iodine-Based Contrast Agents
- Iron-Based Contrast Agents
- Magnetic Particle Imaging Systems
- Manganese-Based Contrast Agents
- Micro-Ct Systems
- Micro-Mri Systems
- Micro-Ultrasound Systems
- Nuclear Imaging Systems
- Optical Imaging Systems
- Other Optical Imaging Systems
- Other Spect Probes
- Photoacoustic Imaging Systems
- Technetium-99M-Based Spect Probes
- Thallium-201-Based Spect Probes
By Application
- Cardiology
- Immunology & Inflammation
- Infectious Diseases
- Neurology
- Oncology
- Other Applications
By End User
- Academic & Research Centers
- Imaging Centers
- Other End Users
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical & Biotech Companies : Need market intelligence to optimize preclinical imaging investments, benchmark R&D spending against competitors, and identify emerging technologies to accelerate drug discovery timelines.
- Medical Device & Imaging Equipment Manufacturers : Require detailed market sizing, growth forecasts, and customer segmentation data to guide product development, sales strategies, and market entry decisions in North America.
- Contract Research Organizations (CROs) : Seek market trends and demand forecasts to justify capital investments in imaging infrastructure, expand service offerings, and capture growing preclinical testing demand.
- Academic & Research Institutions : Need funding and adoption trend data to support grant applications, justify equipment purchases, and understand competitive positioning of their imaging capabilities.
- Investment & Consulting Firms : Require comprehensive market analysis, growth drivers, and competitive insights to inform investment decisions, M&A strategies, and client advisory services in the preclinical imaging sector.
Key Companies in the North America Preclinical Imaging Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| PATHEON INC | Netherlands | Private Company | Optical Imaging (Bioluminescance),PET,SPECT, |
| ANALOGIC CORPORATION | United States | Private Company | MRI,PET,SPECT, |
| XILINX, INC. | United States | Private Company | Optical Imaging (Bioluminescance),PET,SPECT, |
| GUERBET GROUP | France | InvalidIdentifier | PET,SPECT,MRI, |
| BRUKER CORPORATION | United States | Public Company | MRI,PET,SPECT, |
| REVVITY, INC. | United States | Public Company | Optical Imaging (Bioluminescance),PET,SPECT, |
| OPTISCAN IMAGING LTD. | Australia | Public Company | Optical Imaging (Bioluminescance),PET,SPECT, |
PATHEON INC
Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and life sciences sector.
ANALOGIC CORPORATION
Analogic Corporation is a United States-based private company founded in 1967 with 1,510 employees, specializing in medical and aerospace technology solutions.
XILINX, INC.
Xilinx, Inc. is a United States-based private company founded in 1984 with 4,890 employees, operating in the semiconductor and programmable logic industry.
GUERBET GROUP
Guerbet Group is a France-based company in the medical imaging and pharmaceutical sector.
BRUKER CORPORATION
Bruker Corporation is a United States-based public company founded in 1960 with 11,085 employees, providing scientific instruments and analytical solutions.
REVVITY, INC.
Revvity, Inc. is a United States-based public company founded in 1937 with 11,000 employees, operating in the life sciences and diagnostics industry.
OPTISCAN IMAGING LTD.
Optiscan Imaging Ltd. is an Australia-based public company founded in 1994 with 9 employees, specializing in optical imaging technology.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 141.1 Million |
| Canada | USD 25.2 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($1,380.1M in 2024) with country-level breakdowns for the US and Canada, enabling accurate budget allocation and revenue projections.
- Competitive Landscape Intelligence : Understand market dynamics specific to North America's pharmaceutical and academic sectors, identifying key players, market share distribution, and competitive positioning strategies.
- Growth Driver Analysis : Gain insights into region-specific factors driving 5.1% CAGR growth, including R&D spending patterns, regulatory requirements, and technology adoption rates across North American institutions.
- Investment & Expansion Strategy : Leverage detailed market segmentation and opportunity assessment to identify high-potential customer segments, geographic hotspots, and expansion opportunities within North America.
- Regulatory & Funding Landscape : Access analysis of North American funding mechanisms (NIH, NSF, private grants) and regulatory frameworks that influence preclinical imaging adoption and technology requirements.
Frequently asked questions
What is the current size of the preclinical imaging market in North America?
North America's preclinical imaging market was valued at $1,380.1 million in 2024 and is expected to reach $1,768.1 million by 2029.
What is the growth rate of the preclinical imaging market in North America?
North America's preclinical imaging market is growing at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.
Which imaging technologies are most widely used in North America's preclinical research?
North America extensively uses micro-CT, micro-MRI, optical imaging, and bioluminescence imaging systems for preclinical drug discovery and development.
What factors are driving growth in North America's preclinical imaging market?
North America's market growth is driven by increased pharmaceutical R&D spending, expansion of academic research institutions, growing adoption of advanced imaging modalities, and the presence of major CROs.
How does North America's preclinical imaging market compare to other regions?
North America represents a leading market segment globally, characterized by early technology adoption, high investment in research infrastructure, and strong regulatory support for preclinical imaging applications.
RESEARCH METHODOLOGY
This market research study utilized extensive secondary sources, directories, and databases to identify and collect information relevant to this technical, market-oriented, and financial analysis of the preclinical imaging market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to gather and verify critical qualitative and quantitative information, as well as to assess market prospects. The size of the preclinical imaging market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was employed to identify and collect information relevant to the comprehensive, technical, market-oriented, and commercial study of the preclinical imaging market. It was also used to obtain important information about key players, market classification, and segmentation according to industry trends, as well as key developments related to market and technology perspectives, down to the most detailed level. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring a basic understanding of the global preclinical imaging market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
Breakdown of Primary Interviews
Note: Tiers are defined based on the total revenues of companies. As of 2024, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the global preclinical imaging market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- Key players in the global preclinical imaging market were identified through secondary research, and their global market shares were determined through primary and secondary research.
- The research methodology included the study of the annual and quarterly financial reports and regulatory filings, data books of major market players, and interviews with industry experts for detailed market insights.
- All percentage shares, splits, and breakdowns for the global preclinical imaging market were determined by using secondary sources and verified through primary sources.
- All key macroindicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get validated and verified quantitative and qualitative data.
- The gathered market data was consolidated and added with detailed inputs and analysis and presented in this report.
Global Preclinical Imaging Market: Bottom-up and Top-down Approach
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the preclinical imaging market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the preclinical imaging market.
Market Definition
Preclinical imaging involves the application of molecular imaging for the assessment of anatomical, physiological, and functional parameters in live animal models during preclinical studies. Preclinical imaging systems and reagents are utilized to visualize living animals in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications. During preclinical studies, a variety of different imaging modalities are utilized, such as optical imaging systems, nuclear imaging systems (micro-PET and micro-SPECT), micro-MRI, micro-ultrasound systems, and micro-CT imaging systems.
Stakeholders
- Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers
- Pharmaceutical and Biotechnology Companies
- Preclinical Imaging Reagent Manufacturers and Suppliers
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Medical Research Laboratories
- Academic Medical Institutes and Universities
- Market Research and Consulting Service Providers
Report Objectives
- To define, describe, and forecast the preclinical imaging market by product type, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
-
To analyze the opportunities in the market for stakeholders and provide details of
the competitive landscape for preclinical imaging market leaders - To profile the key players in the market and comprehensively analyze their market shares and core competencies
-
To forecast the size of the market segments with respect to five main regions:
North America, the Asia Pacific, Europe, Latin America, and the Middle East & Africa - To track and analyze competitive developments, such as partnerships, acquisitions, product launches & approvals, and expansions
- To benchmark players within the preclinical imaging market using the Competitive Evaluation Matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering
Get the Full Preclinical Imaging Market Report
Full forecast, segment splits, and company analysis for all Preclinical Imaging Market.
- US Preclinical Imaging Market
- Canada Preclinical Imaging Market
- Germany Preclinical Imaging Market
- UK Preclinical Imaging Market
- France Preclinical Imaging Market
- Italy Preclinical Imaging Market
- Spain Preclinical Imaging Market
- Japan Preclinical Imaging Market
- China Preclinical Imaging Market
- India Preclinical Imaging Market
- Brazil Preclinical Imaging Market
- Mexico Preclinical Imaging Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
